Φορτώνει......
Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: A systematic literature review
AIM: To review literature on efficacy and safety of octreotide-long-acting repeatable (LAR) used at doses higher than the Food and Drug Administration (FDA)-approved 30 mg/mo for treatment of neuroendocrine tumors (NETs). METHODS: We searched PubMed and Cochrane Library from 1998-2012, 5 conferences...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | World J Gastroenterol |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Baishideng Publishing Group Inc
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4323475/ https://ncbi.nlm.nih.gov/pubmed/25684964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i6.1945 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|